Top Mobile Cardiac Telemetry Companies

Global Mobile Cardiac Telemetry Market size was valued at USD 1.01 Billion in 2024 and is poised to grow from USD 1.13 Billion in 2025 to USD 2.82 Billion by 2033, growing at a CAGR of 12.1% during the forecast period (2026–2033).

The mobile cardiac telemetry system market is highly competitive. To increase market penetration, some of the major industry players are engaging in strategic collaborations, regional expansions, and new product launches. VitalConnect, for example, will launch the VitalPatch RTM mobile cardiac telemetry solution in May 2021. The solution has a versatile and programmable platform that can meet a variety of cardiac monitoring requirements. 'Medtronic plc (Ireland) ', 'Koninklijke Philips N.V. (Netherlands) ', 'iRhythm Technologies, Inc. (USA) ', 'Preventice Solutions (USA) ', 'Boston Scientific Corporation (USA) ', 'ScottCare Corporation (USA) ', 'Applied Cardiac Systems, Inc. (USA) ', 'Medicomp, Inc. (USA) ', 'CardioNet, Inc. (USA) ', 'LifeWatch AG (Switzerland) ', 'Bittium Corporation (Finland) ', 'GE Healthcare (USA) ', 'Siemens Healthineers AG (Germany) ', 'Hillrom Holdings, Inc. (USA) ', 'Baxter International Inc. (USA) ', 'AliveCor, Inc. (USA) ', 'InfoBionic, Inc. (USA)'

The increased awareness of emerging patch technology, as well as the introduction of new devices with optimised applications, are driving the growth of the global mobile cardiac telemetry systems market.

Because of the technological advantage, demand for mobile cardiac telemetry systems is expected to grow significantly over the forecast period. Mobile cardiac telemetry systems allow patients to move around and provide physicians with real-time data on their patients.

During the forecast period, North America is expected to dominate the global mobile cardiac telemetry systems market. In the United States, one person dies from cardiovascular disease every 36 seconds. Every year, approximately 659,000 people die from heart disease, accounting for one in every four deaths in the United States. Because of the increasing geriatric population, rising healthcare expenditure, the presence of major service providers with improved healthcare solutions, and the prevalence of cardiac disorders, North America dominates the mobile cardiac telemetry (MCAT) market.